跳至主要内容
临床试验/NCT05675293
NCT05675293尚未招募早期 1 期

Effectiveness of Iontophoresis in Managing Uterine Cervicitis

October 6 University0 个研究点目标入组 40 人开始时间: 2023年1月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
尚未招募
入组人数
40
主要终点
Difference in change in Urine Analysis and Cervical swab results in both groups

研究概览

简要总结

The purpose of the study is to:

Investigate effect of iontophoresis on managing uterine cervicitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • All patients have vaginal discharge.
  • All patients have irregular vaginal bleeding, especially after sexual intercourse.
  • All patients have dyspareunia.
  • All patients have Lower abdominal pain.
  • Group A: 20 women will receive oral medication (antibiotic zesrosin) and hot water with antiseptic.
  • Group B: 20 women will receive medication by iontophoresis (antibiotic ceftriaxone) and hot water with antiseptic.

排除标准

  • Patients with a history of hypersensitivity or adverse reactions associated with the delivered drug in (ceftriaxone).
  • Patients with prior medical histories of cardiac arrhythmias or hypercoagulability should not receive the procedure near cardiac pacemakers and superficial blood vessels.
  • In the vicinity of embedded wires, stapes, orthopedic implants, and areas of skin with lesions and impaired sensation.
  • It either should not be used or used with extreme caution during pregnancy.

研究组 & 干预措施

EXPERIMENTAL ARM

Experimental

干预措施: IONTOPHORESIS (Device)

CONTROL ARM

Active Comparator

干预措施: ORAL ANTIBIOTIC (Drug)

结局指标

主要结局

Difference in change in Urine Analysis and Cervical swab results in both groups

时间窗: 7 Days difference between pre and post tests

Presence of Pus Cells in Urine Analysis and a Positive Cervical swab results

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

MARIAM HELMY

Practitioner

October 6 University

相似试验